PCV81 Cost-Effectiveness of Apixaban For Stroke Prevention In Atrial Fibrillation: An Kazakhstan Perspective

Kostyuk, A; Almadiyeva, A; Nurgozhin, T

NUR Home
→
02.National Laboratory Astana
→
Articles
→
View Item

Система будет остановлена для регулярного обслуживания. Пожалуйста, сохраните рабочие данные и выйдите из системы.

dc.contributor.author	Kostyuk, A
dc.contributor.author	Almadiyeva, A
dc.contributor.author	Nurgozhin, T
dc.creator	A, Kostyuk
dc.date.accessioned	2017-12-20T08:55:06Z
dc.date.available	2017-12-20T08:55:06Z
dc.date.issued	2017-10-01
dc.identifier	DOI:10.1016/j.jval.2017.08.1227
dc.identifier.citation	A Kostyuk, A Almadiyeva, T Nurgozhin, PCV81 - Cost-Effectiveness of Apixaban For Stroke Prevention In Atrial Fibrillation: An Kazakhstan Perspective, In Value in Health, Volume 20, Issue 9, 2017, Page A615	en_US
dc.identifier.issn	10983015
dc.identifier.uri	https://www.sciencedirect.com/science/article/pii/S1098301517315619
dc.identifier.uri	http://nur.nu.edu.kz/handle/123456789/2963
dc.description.abstract	Apixaban, dabigatran, and rivaroxaban are 3 novel oral anticoagulants (NOACs) currently approved for stroke prevention in patients with atrial fibrillation (AF). Although warfarin remains the standard of care in Kazakhstan.The objective of this study was to evaluate the cost-effectiveness of apixaban against other NOACs and warfarin from the considering costs and savings for public payers perspective in Kazakhstan	en_US
dc.language.iso	en	en_US
dc.publisher	Value in Health	en_US
dc.relation.ispartof	Value in Health
dc.title	PCV81 Cost-Effectiveness of Apixaban For Stroke Prevention In Atrial Fibrillation: An Kazakhstan Perspective	en_US
dc.type	Article	en_US
dc.rights.license	Copyright © 2017 Published by Elsevier Inc.
elsevier.identifier.doi	10.1016/j.jval.2017.08.1227
elsevier.identifier.eid	1-s2.0-S1098301517315619
elsevier.identifier.pii	S1098-3015(17)31561-9
elsevier.volume	20
elsevier.issue.identifier	9
elsevier.coverdate	2017-10-01
elsevier.coverdisplaydate	October–November 2017
elsevier.startingpage	A615
elsevier.openaccess	0
elsevier.openaccessarticle	false
elsevier.openarchivearticle	false
elsevier.aggregationtype	Journal
workflow.import.source	science